<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35632761</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>11</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1020</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14051020</ELocationID><Abstract><AbstractText>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) not only affects the respiratory tract but also causes neurological symptoms such as loss of smell and taste, headache, fatigue or severe cerebrovascular complications. Using transgenic mice expressing human angiotensin-converting enzyme 2 (hACE2), we investigated the spatiotemporal distribution and pathomorphological features in the CNS following intranasal infection with SARS-CoV-2 variants, as well as after prior influenza A virus infection. Apart from Omicron, we found all variants to frequently spread to and within the CNS. Infection was restricted to neurons and appeared to spread from the olfactory bulb mainly in basally oriented regions in the brain and into the spinal cord, independent of ACE2 expression and without evidence of neuronal cell death, axonal damage or demyelination. However, microglial activation, microgliosis and a mild macrophage and T cell dominated inflammatory response was consistently observed, accompanied by apoptotic death of endothelial, microglial and immune cells, without their apparent infection. Microgliosis and immune cell apoptosis indicate a potential role of microglia for pathogenesis and viral effect in COVID-19 and the possible impairment of neurological functions, especially in long COVID. These data may also be informative for the selection of therapeutic candidates and broadly support the investigation of agents with adequate penetration into relevant regions of the CNS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seehusen</LastName><ForeName>Frauke</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory for Animal Model Pathology, Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Jordan J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0003-1790-7883</Identifier><AffiliationInfo><Affiliation>Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Parul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bentley</LastName><ForeName>Eleanor G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirby</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subramaniam</LastName><ForeName>Krishanthi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wunderlin-Giuliani</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory for Animal Model Pathology, Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Grant L</ForeName><Initials>GL</Initials><Identifier Source="ORCID">0000-0002-7567-7185</Identifier><AffiliationInfo><Affiliation>Departments of Vector Biology and Tropical Disease Biology, Centre for Neglected Tropical Disease, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patterson</LastName><ForeName>Edward I</ForeName><Initials>EI</Initials><Identifier Source="ORCID">0000-0003-3465-0848</Identifier><AffiliationInfo><Affiliation>Departments of Vector Biology and Tropical Disease Biology, Centre for Neglected Tropical Disease, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michael</LastName><ForeName>Benedict D</ForeName><Initials>BD</Initials><Identifier Source="ORCID">0000-0002-8693-8926</Identifier><AffiliationInfo><Affiliation>Department of Clinical Infection Microbiology and Immunology and NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary, and Ecological Sciences, University of Liverpool, Liverpool L69 7BE, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool L9 7AL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owen</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9819-7651</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Centre of Excellence in Long-Acting Therapeutics (CELT), University of Liverpool, Liverpool L3 3NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiscox</LastName><ForeName>Julian A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>James P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-8928-2037</Identifier><AffiliationInfo><Affiliation>Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kipar</LastName><ForeName>Anja</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7289-3459</Identifier><AffiliationInfo><Affiliation>Laboratory for Animal Model Pathology, Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 5RF, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/W005611/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/T028750/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V007181//1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V03605X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V007181/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>75F40120C00085</GrantID><Acronym>FD</Acronym><Agency>FDA HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ISSF201902/3</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="Y">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="Y">Central Nervous System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056189" MajorTopicYN="Y">Viral Tropism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Severe Acute Respiratory Syndrome Coronavirus 2</Keyword><Keyword MajorTopicYN="N">encephalitis</Keyword><Keyword MajorTopicYN="N">influenza A virus coinfection</Keyword><Keyword MajorTopicYN="N">microgliosis</Keyword><Keyword MajorTopicYN="N">mouse model</Keyword><Keyword MajorTopicYN="N">virus variants</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35632761</ArticleId><ArticleId IdType="pmc">PMC9146514</ArticleId><ArticleId IdType="doi">10.3390/v14051020</ArticleId><ArticleId IdType="pii">v14051020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bernard-Valnet R., Pizzarotti B., Anichini A., Demars Y., Russo E., Schmidhauser M., Cerutti-Sola J., Rossetti A.O., Du Pasquier R. Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection. Eur. J. Neurol. 2020;27:e43&#x2013;e44. doi: 10.1111/ene.14298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14298</ArticleId><ArticleId IdType="pmc">PMC7267660</ArticleId><ArticleId IdType="pubmed">32383343</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., Collange O., Boulay C., Fafi-Kremer S., Ohana M., et al. Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med. 2020;382:2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.H., Jiang D., Huang J.T. SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav. Immun. 2020;87:149. doi: 10.1016/j.bbi.2020.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7202824</ArticleId><ArticleId IdType="pubmed">32387508</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T., Harii N., Goto J., Harada D., Sugawara H., Takamino J., Ueno M., Sakata H., Kondo K., Myose N., et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 2020;94:55&#x2013;58. doi: 10.1016/j.ijid.2020.03.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley T.J., Mocco J., Majidi S., Kellner C.P., Shoirah H., Singh I.P., De Leacy R.A., Shigematsu T., Ladner T.R., Yaeger K.A., et al. Large-vessel stroke as a presenting feature of COVID-19 in the young. N. Engl. J. Med. 2020;382:e60. doi: 10.1056/NEJMc2009787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyiadji N., Shahin G., Noujaim D., Stone M., Patel S., Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: Imaging features. Radiology. 2020;296:E119&#x2013;E120. doi: 10.1148/radiol.2020201187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201187</ArticleId><ArticleId IdType="pmc">PMC7233386</ArticleId><ArticleId IdType="pubmed">32228363</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J., Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856&#x2013;860. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., Sperhake J.P., Schr&#xf6;der A.S., Edler C., Mushumba H., Fitzek A., Allweiss L., Dandri M., et al. Neuropathology of patients with COVID-19 in Germany: A post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Br&#xfc;nink S., Greuel S., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Yoo S.J., Clijsters M., Backaert W., Vanstapel A., Speleman K., Lietaer C., Choi S., Hether T.D., Marcelis L., et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell. 2021;184:5932&#x2013;5949.e15. doi: 10.1016/j.cell.2021.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.027</ArticleId><ArticleId IdType="pmc">PMC8564600</ArticleId><ArticleId IdType="pubmed">34798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A., Bryce C., Grimes Z., Gordon R.E., Reidy J., Lednicky J., Sordillo E.M., Fowkes M. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J. Med. Virol. 2020;92:699&#x2013;702. doi: 10.1002/jmv.25915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25915</ArticleId><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraj S., Troakes C., Hanley B., Osborn M., Richardson M.P., Hotopf M., Bullmore E., Everall I.P. Invited Review: The spectrum of neuropathology in COVID-19. Neuropathol. Appl. Neurobiol. 2021;47:3&#x2013;16. doi: 10.1111/nan.12667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12667</ArticleId><ArticleId IdType="pubmed">32935873</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsmith C.S., Miller S.E., Martines R.B., Bullock H.A., Zaki S.R. Electron microscopy of SARS-CoV-2: A challenging task. Lancet. 2020;395:e99. doi: 10.1016/S0140-6736(20)31188-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31188-0</ArticleId><ArticleId IdType="pmc">PMC7237172</ArticleId><ArticleId IdType="pubmed">32442529</ArticleId></ArticleIdList></Reference><Reference><Citation>Deigendesch N., Sironi L., Kutza M., Wischnewski S., Fuchs V., Hench J., Frank A., Nienhold R., Mertz K.D., Cathomas G., et al. Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology. Acta Neuropathol. 2020;140:583&#x2013;586. doi: 10.1007/s00401-020-02213-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02213-y</ArticleId><ArticleId IdType="pmc">PMC7449525</ArticleId><ArticleId IdType="pubmed">32851506</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri V.P., Foschini M.P., Lazzarotto T., Gabrielli L., Cenacchi G., Gallo C., Aspide R., Frascaroli G., Cortelli P., Riefolo M., et al. Brain ischemic injury in COVID-19-infected patients: A series of 10 post-mortem cases. Brain Pathol. 2021;31:205&#x2013;210. doi: 10.1111/bpa.12901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12901</ArticleId><ArticleId IdType="pmc">PMC7536900</ArticleId><ArticleId IdType="pubmed">33002281</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaunmuktane Z., Mahadeva U., Green A., Sekhawat V., Barrett N.A., Childs L., Shankar-Hari M., Thom M., J&#xe4;ger H.R., Brandner S. Microvascular injury and hypoxic damage: Emerging neuropathological signatures in COVID-19. Acta Neuropathol. 2020;140:397&#x2013;400. doi: 10.1007/s00401-020-02190-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02190-2</ArticleId><ArticleId IdType="pmc">PMC7340758</ArticleId><ArticleId IdType="pubmed">32638079</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantonen J., Mahzabin S., M&#xe4;yr&#xe4;np&#xe4;&#xe4; M.I., Tynninen O., Paetau A., Andersson N., Sajantila A., Vapalahti O., Carp&#xe9;n O., Kek&#xe4;l&#xe4;inen E., et al. Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. 2020;30:1012&#x2013;1016. doi: 10.1111/bpa.12889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12889</ArticleId><ArticleId IdType="pmc">PMC7436498</ArticleId><ArticleId IdType="pubmed">32762083</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichard R.R., Kashani K.B., Boire N.A., Constantopoulos E., Guo Y., Lucchinetti C.F. Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020;140:1&#x2013;6. doi: 10.1007/s00401-020-02166-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02166-2</ArticleId><ArticleId IdType="pmc">PMC7245994</ArticleId><ArticleId IdType="pubmed">32449057</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurink B., Roos E., Radonic T., Barbe E., Bouman C.S.C., de Boer H.H., de Bree G.J., Bulle E.B., Aronica E.M., Florquin S., et al. Viral presence and immunopathology in patients with lethal COVID-19: A prospective autopsy cohort study. Lancet Microbe. 2020;1:e290&#x2013;e299. doi: 10.1016/S2666-5247(20)30144-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30144-0</ArticleId><ArticleId IdType="pmc">PMC7518879</ArticleId><ArticleId IdType="pubmed">33015653</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon I.H., Normandin E., Bhattacharyya S., Mukerji S.S., Keller K., Ali A.S., Adams G., Hornick J.L., Padera R.F., Jr., Sabeti P. Neuropathological features of Covid-19. N. Engl. J. Med. 2020;383:989&#x2013;992. doi: 10.1056/NEJMc2019373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2019373</ArticleId><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>von Weyhern C.H., Kaufmann I., Neff F., Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet. 2020;395:e109. doi: 10.1016/S0140-6736(20)31282-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31282-4</ArticleId><ArticleId IdType="pmc">PMC7272176</ArticleId><ArticleId IdType="pubmed">32505222</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dalahmah O., Thakur K.T., Nordvig A.S., Prust M.L., Roth W., Lignelli A., Uhlemann A.C., Miller E.H., Kunnath-Velayudhan S., Del Portillo A., et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol. Commun. 2020;8:147. doi: 10.1186/s40478-020-01024-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01024-2</ArticleId><ArticleId IdType="pmc">PMC7447601</ArticleId><ArticleId IdType="pubmed">32847628</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R., Schneider E., Zentilin L., Collesi C., Ali H., Braga L., Volpe M.C., Colliva A., Zanconati F., Berlot G., et al. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine. 2020;61:103104. doi: 10.1016/j.ebiom.2020.103104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103104</ArticleId><ArticleId IdType="pmc">PMC7677597</ArticleId><ArticleId IdType="pubmed">33158808</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles V.G., L&#xfc;tgehetmann M., Lindenmeyer M.T., Sperhake J.P., Wong M.N., Allweiss L., Chilla S., Heinemann A., Wanner N., Liu S., et al. Multiorgan and renal tropism of SARS-CoV-2. N. Engl. J. Med. 2020;383:590&#x2013;592. doi: 10.1056/NEJMc2011400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar S., Najjar A., Chong D.J., Pramanik B.K., Kirsch C., Kuzniecky R.I., Pacia S.V., Azhar S. Central nervous system complications associated with SARS-CoV-2 infection: Integrative concepts of pathophysiology and case reports. J. Neuroinflamm. 2020;17:231. doi: 10.1186/s12974-020-01896-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01896-0</ArticleId><ArticleId IdType="pmc">PMC7406702</ArticleId><ArticleId IdType="pubmed">32758257</ArticleId></ArticleIdList></Reference><Reference><Citation>Murta V., Villarreal A., Ramos A.J. Severe Acute Respiratory Syndrome Coronavirus 2 impact on the central nervous system: Are astrocytes and microglia main players or merely bystanders? ASN Neuro. 2020;12:1759091420954960. doi: 10.1177/1759091420954960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759091420954960</ArticleId><ArticleId IdType="pmc">PMC7476346</ArticleId><ArticleId IdType="pubmed">32878468</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas G., Medeiros Geraldo L.H., Gede&#xe3;o Salom&#xe3;o N., Viana Paes M., Regina Souza Lima F., Carvalho Alcantara Gomes F. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives. Brain Behav. Immun. Health. 2020;7:100127. doi: 10.1016/j.bbih.2020.100127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100127</ArticleId><ArticleId IdType="pmc">PMC7423575</ArticleId><ArticleId IdType="pubmed">32838339</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry V.H., Cunningham C., Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 2007;7:161&#x2013;167. doi: 10.1038/nri2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2015</ArticleId><ArticleId IdType="pubmed">17220915</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry V.H., Teeling J. Microglia and macrophages of the central nervous system: The contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin. Immunopathol. 2013;35:601&#x2013;612. doi: 10.1007/s00281-013-0382-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-013-0382-8</ArticleId><ArticleId IdType="pmc">PMC3742955</ArticleId><ArticleId IdType="pubmed">23732506</ArticleId></ArticleIdList></Reference><Reference><Citation>Murta V., Far&#xed;as M.I., Pitossi F.J., Ferrari C.C. Chronic systemic IL-1&#x3b2; exacerbates central neuroinflammation independently of the blood-brain barrier integrity. J. Neuroimmunol. 2015;278:30&#x2013;43. doi: 10.1016/j.jneuroim.2014.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2014.11.023</ArticleId><ArticleId IdType="pubmed">25595250</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson P.A., II, McGavern D.B. Viral diseases of the central nervous system. Curr. Opin. Virol. 2015;11:44&#x2013;54. doi: 10.1016/j.coviro.2014.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.12.009</ArticleId><ArticleId IdType="pmc">PMC4456224</ArticleId><ArticleId IdType="pubmed">25681709</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea E.M., Logsdon A.F., Hansen K.M., Williams L.M., Reed M.J., Baumann K.K., Holden S.J., Raber J., Banks W.A., Erickson M.A. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat. Neurosci. 2020;24:368&#x2013;378. doi: 10.1038/s41593-020-00771-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael B.D., Bricio-Moreno L., Sorensen E.W., Miyabe Y., Lian J., Solomon T., Kurt-Jones E.A., Luster A.D. Astrocyte- and neuron-derived CXCL1 drives neutrophil transmigration and blood-brain barrier permeability in viral encephalitis. Cell Rep. 2020;32:108150. doi: 10.1016/j.celrep.2020.108150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108150</ArticleId><ArticleId IdType="pmc">PMC7548103</ArticleId><ArticleId IdType="pubmed">32937134</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F., Carregari V.C., Veras F.P., Vendramini P.H., Valen&#xe7;a A.G.F., Antunes A.S.L.M., Brand&#xe3;o-Teles C., da Silva Zuccoli G., Reis-de-Oliveira G., Silva-Costa L.C., et al. Morphological, cellular and molecular basis of brain infection in COVID-19 patients. medRxiv. 2022 doi: 10.1101/2020.10.09.20207464. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.09.20207464</ArticleId><ArticleId IdType="pmc">PMC9436354</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam S.B., Willows S., Kulka M., Sandhu J.K. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system. Eur. J. Neurol. 2020;27:2348&#x2013;2360. doi: 10.1111/ene.14442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14442</ArticleId><ArticleId IdType="pmc">PMC7405269</ArticleId><ArticleId IdType="pubmed">32668062</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalaxmi I., Kaavya J., Mohana Devi S., Balachandar V. COVID-19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases. J. Cell Physiol. 2021;236:763&#x2013;770. doi: 10.1002/jcp.29937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.29937</ArticleId><ArticleId IdType="pmc">PMC7405062</ArticleId><ArticleId IdType="pubmed">32697344</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavi E., Cong L. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection. Exp. Mol. Pathol. 2020;115:104474. doi: 10.1016/j.yexmp.2020.104474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2020.104474</ArticleId><ArticleId IdType="pmc">PMC7245307</ArticleId><ArticleId IdType="pubmed">32454103</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280.e278. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>McCray P.B., Jr., Pewe L., Wohlford-Lenane C., Hickey M., Manzel L., Shi L., Netland J., Jia H.P., Halabi C., Sigmund C.D., et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 2007;81:813&#x2013;821. doi: 10.1128/JVI.02012-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02012-06</ArticleId><ArticleId IdType="pmc">PMC1797474</ArticleId><ArticleId IdType="pubmed">17079315</ArticleId></ArticleIdList></Reference><Reference><Citation>Carossino M., Kenney D., O&#x2019;Connell A.K., Montanaro P., Tseng A.E., Gertje H.P., Grosz K.A., Ericsson M., Huber B.R., Kurnick S.A., et al. Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression. Viruses. 2022;14:535. doi: 10.3390/v14030535.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030535</ArticleId><ArticleId IdType="pmc">PMC8955233</ArticleId><ArticleId IdType="pubmed">35336942</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark J.J., Penrice-Randal R., Sharma P., Kipar A., Dong X., Davidson A., Kavanagh Williamson M., Matthews D.A., Turtle L., Prince T., et al. Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19. bioRxiv. 2021 doi: 10.1101/2020.10.13.334532. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.13.334532</ArticleId><ArticleId IdType="pmc">PMC11209060</ArticleId><ArticleId IdType="pubmed">38932155</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari P., Rothan H.A., Natekar J.P., Stone S., Pathak H., Strate P.G., Arora K., Brinton M.A., Kumar M. Neuroinvasion and encephalitis following intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice. Viruses. 2021;13:132. doi: 10.3390/v13010132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010132</ArticleId><ArticleId IdType="pmc">PMC7832889</ArticleId><ArticleId IdType="pubmed">33477869</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal E., L&#xf3;pez-Figueroa C., Rodon J., P&#xe9;rez M., Brustolin M., Cantero G., Guallar V., Izquierdo-Useros N., Carrillo J., Blanco J., et al. Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice. Vet. Pathol. 2021 doi: 10.1177/03009858211066841. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03009858211066841</ArticleId><ArticleId IdType="pmc">PMC9207990</ArticleId><ArticleId IdType="pubmed">34955064</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson E.I., Prince T., Anderson E.R., Casas-Sanchez A., Smith S.L., Cansado-Utrilla C., Solomon T., Griffiths M.J., Acosta-Serrano &#xc1;., Turtle L., et al. Methods of inactivation of SARS-CoV-2 for downstream biological assays. J. Infect. Dis. 2020;222:1462&#x2013;1467. doi: 10.1093/infdis/jiaa507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa507</ArticleId><ArticleId IdType="pmc">PMC7529010</ArticleId><ArticleId IdType="pubmed">32798217</ArticleId></ArticleIdList></Reference><Reference><Citation>Cele S., Gazy I., Jackson L., Hwa S.H., Tegally H., Lustig G., Giandhari J., Pillay S., Wilkinson E., Naidoo Y., et al. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature. 2021;593:142&#x2013;146. doi: 10.1038/s41586-021-03471-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03471-w</ArticleId><ArticleId IdType="pmc">PMC9867906</ArticleId><ArticleId IdType="pubmed">33780970</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W., Shaw R.H., Supasa P., Liu C., Stuart A.S., Pollard A.J., Liu X., Lambe T., Crook D., Stuart D.I., et al. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. Lancet. 2022;399:234&#x2013;236. doi: 10.1016/S0140-6736(21)02844-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02844-0</ArticleId><ArticleId IdType="pmc">PMC8687667</ArticleId><ArticleId IdType="pubmed">34942101</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentley E.G., Kirby A., Sharma P., Kipar A., Mega D.F., Bramwell C., Penrice-Randal R., Prince T., Brown J.C., Zhou J., et al. SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19. bioRxiv. 2021 doi: 10.1101/2021.12.26.474085. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.26.474085</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzer R., Clark J.J., Vaysburd M., Chang V.T., Albecka A., Kiss L., Sharma P., Gonzalez Llamazares A., Kipar A., Hiscox J.A., et al. Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice. FEBS Lett. 2021;595:2323&#x2013;2340. doi: 10.1002/1873-3468.14171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.14171</ArticleId><ArticleId IdType="pmc">PMC8426897</ArticleId><ArticleId IdType="pubmed">34331769</ArticleId></ArticleIdList></Reference><Reference><Citation>Salguero F.J., White A.D., Slack G.S., Fotheringham S.A., Bewley K.R., Gooch K.E., Longet S., Humphries H.E., Watson R.J., Hunter L., et al. Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19. Nat. Commun. 2021;12:1260. doi: 10.1038/s41467-021-21389-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21389-9</ArticleId><ArticleId IdType="pmc">PMC7904795</ArticleId><ArticleId IdType="pubmed">33627662</ArticleId></ArticleIdList></Reference><Reference><Citation>Saura-Martinez H., Al-Saadi M., Stewart J.P., Kipar K. Sheep-associated malignant catarrhal fever: Role of latent virus and macrophages in vasculitis. Vet. Pathol. 2021;58:332&#x2013;345. doi: 10.1177/0300985820978310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300985820978310</ArticleId><ArticleId IdType="pubmed">33280543</ArticleId></ArticleIdList></Reference><Reference><Citation>3d Viewer: Allen Brain Atlas: Mouse Connectivity.  [(accessed on 8 March 2022)].  Available online:  https://connectivity.brain-map.org/3d-viewer?v=1&amp;types=PLY&amp;PLY=453%2C1057%2C31%2C44%2C254%2C500%2C922%2C895%2C549%2C1097%2C386%2C370%2C1132%2C987%2C669%2C1089%2C672%2C502%2C909%2C961%2C972%2C507.</Citation></Reference><Reference><Citation>Oladunni F.S., Park J.G., Pino P.A., Gonzalez O., Akhter A., Allu&#xe9;-Guardia A., Olmo-Font&#xe1;nez A., Gautam S., Garcia-Vilanova A., Ye C., et al. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nat. Commun. 2020;11:6122. doi: 10.1038/s41467-020-19891-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19891-7</ArticleId><ArticleId IdType="pmc">PMC7705712</ArticleId><ArticleId IdType="pubmed">33257679</ArticleId></ArticleIdList></Reference><Reference><Citation>Yinda C.K., Port J.R., Bushmaker T., Offei Owusu I., Purushotham J.N., Avanzato V.A., Fischer R.J., Schulz J.E., Holbrook M.G., Hebner M.J., et al. K18-hACE2 mice develop respiratory disease resembling severe COVID-19. PLoS Pathog. 2021;17:e1009195. doi: 10.1371/journal.ppat.1009195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009195</ArticleId><ArticleId IdType="pmc">PMC7875348</ArticleId><ArticleId IdType="pubmed">33465158</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J., Wong L.Y.R., Li K., Verma A.K., Ortiz M.E., Wohlford-Lenane C., Leidinger M.R., Knudson C.M., Meyerholz D.K., McCray P.B., et al. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature. 2021;589:603&#x2013;607. doi: 10.1038/s41586-020-2943-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2943-z</ArticleId><ArticleId IdType="pmc">PMC7855185</ArticleId><ArticleId IdType="pubmed">33166988</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfmann P.J., Iida S., Iwatsuki-Horimoto K., Maemura T., Kiso M., Scheaffer S.M., Darling T.L., Joshi A., Loeber S., Singh G., et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature. 2022;603:687&#x2013;692. doi: 10.1038/s41586-022-04441-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04441-6</ArticleId><ArticleId IdType="pmc">PMC8942849</ArticleId><ArticleId IdType="pubmed">35062015</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhatib M., Salpini R., Carioti L., Ambrosio F.A., D&#x2019;Anna S., Duca L., Costa G., Bellocchi M.C., Piermatteo L., Artese A., et al. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile. Microbiol. Spectr. 2022;10:e0273221. doi: 10.1128/spectrum.02732-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02732-21</ArticleId><ArticleId IdType="pmc">PMC9045195</ArticleId><ArticleId IdType="pubmed">35352942</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal R., Deb S., Shome G., Ganguly U., Lahiri D., Leon J.B. Spectrum of spinal cord involvement in COVID-19: A systematic review. medRxiv. 2020 doi: 10.1101/2020.09.29.20203554. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.29.20203554</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G.A., Wells M. Neuropil vacuolation in brain: A reproducible histological processing artefact. J. Comp. Pathol. 1989;101:355&#x2013;362. doi: 10.1016/0021-9975(89)90018-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9975(89)90018-2</ArticleId><ArticleId IdType="pubmed">2691536</ArticleId></ArticleIdList></Reference><Reference><Citation>Wohlsein P., Deschl U., Baumg&#xe4;rtner W. Nonlesions, unusual cell types, and postmortem artifacts in the central nervous system of domestic animals. Vet. Pathol. 2013;50:122&#x2013;143. doi: 10.1177/0300985812450719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300985812450719</ArticleId><ArticleId IdType="pubmed">22692622</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner I., Spivack J.G., Deshmane S.L., Ace C.I., Preston C.M., Fraser N.W. A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. J. Virol. 1990;64:1630&#x2013;1638. doi: 10.1128/jvi.64.4.1630-1638.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.64.4.1630-1638.1990</ArticleId><ArticleId IdType="pmc">PMC249299</ArticleId><ArticleId IdType="pubmed">2157048</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E.S., Bailey A.L., Kafai N.M., Nair S., McCune B.T., Yu J., Fox J.M., Chen R.E., Earnest J.T., Keeler S.P., et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nature Immunol. 2020;21:1327&#x2013;1335. doi: 10.1038/s41590-020-0778-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0778-2</ArticleId><ArticleId IdType="pmc">PMC7578095</ArticleId><ArticleId IdType="pubmed">32839612</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay M.E., Madore C., Bordeleau M., Tian L., Verkhratsky A. Neuropathobiology of COVID-19: The role for glia. Front. Cell Neurosci. 2020;14:592214. doi: 10.3389/fncel.2020.592214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.592214</ArticleId><ArticleId IdType="pmc">PMC7693550</ArticleId><ArticleId IdType="pubmed">33304243</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai L., Zhao Y., Dong J., Liang S., Guo M., Liu X., Wang X., Huang Z., Sun X., Zhang Z., et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res. 2021;31:395&#x2013;403. doi: 10.1038/s41422-021-00473-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00473-1</ArticleId><ArticleId IdType="pmc">PMC7890106</ArticleId><ArticleId IdType="pubmed">33603116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita T., Watanabe K., Sakurai Y., Nishi K., Yoshikawa R., Yasuda J. Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters. Sci Rep. 2021;11:21259. doi: 10.1038/s41598-021-00809-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00809-2</ArticleId><ArticleId IdType="pmc">PMC8553868</ArticleId><ArticleId IdType="pubmed">34711897</ArticleId></ArticleIdList></Reference><Reference><Citation>Askew K., Li K., Olmos-Alonso A., Garcia-Moreno F., Liang Y., Richardson P., Tipton T., Chapman M.A., Riecken K., Beccari S., et al. Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain. Cell Rep. 2017;18:391&#x2013;405. doi: 10.1016/j.celrep.2016.12.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.12.041</ArticleId><ArticleId IdType="pmc">PMC5263237</ArticleId><ArticleId IdType="pubmed">28076784</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.H., Wood J., Yal&#xe7;&#x131;n B., Taylor K.R., Dutton S., Acosta-Alvarez L., et al. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv. 2022 doi: 10.1101/2022.01.07.475453. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothan H.A., Kumari P., Stone S., Natekar J.P., Arora K., Auroni T.T., Kumar M. SARS-CoV-2 Infects Primary Neurons from Human ACE2 Expressing Mice and Upregulates Genes Involved in the Inflammatory and Necroptotic Pathways. Pathogens. 2022;11:257. doi: 10.3390/pathogens11020257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020257</ArticleId><ArticleId IdType="pmc">PMC8876293</ArticleId><ArticleId IdType="pubmed">35215199</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Colagrossi L., Antonello M., Renica S., Merli M., Matarazzo E., Travi G., Vecchi M., Colombo J., Muscatello A., Grasselli G., et al. SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: A cross-sectional proof-of-concept study. BMC Infect. Dis. 2021;21:184. doi: 10.1186/s12879-021-05886-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05886-2</ArticleId><ArticleId IdType="pmc">PMC7887543</ArticleId><ArticleId IdType="pubmed">33596855</ArticleId></ArticleIdList></Reference><Reference><Citation>Comer S.P., Cullivan S., Szklanna P.B., Weiss L., Cullen S., Kelliher S., Smolenski A., Murphy C., Altaie H., Curran J., et al. COVID-19 induces a hyperactive phenotype in circulating platelets. PLoS Biol. 2021;19:e3001109. doi: 10.1371/journal.pbio.3001109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001109</ArticleId><ArticleId IdType="pmc">PMC7920383</ArticleId><ArticleId IdType="pubmed">33596198</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Tacquard C., Severac F., Leonard-Lorant I., Ohana M., Delabranche X., Merdji H., Clere-Jehl R., Schenck M., Fagot Gandet F., et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med. 2020;46:1089&#x2013;1098. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D., Kant K.M., Kaptein F.H.J., van Paassen J., Stals M.A.M., Huisman M.V., et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020;191:148&#x2013;150. doi: 10.1016/j.thromres.2020.04.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.041</ArticleId><ArticleId IdType="pmc">PMC7192101</ArticleId><ArticleId IdType="pubmed">32381264</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryche B., St Albin A., Murri S., Lac&#xf4;te S., Pulido C., Ar Gouilh M., Lesellier S., Servat A., Wasniewski M., Picard-Meyer E., et al. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav. Immun. 2020;89:579&#x2013;586. doi: 10.1016/j.bbi.2020.06.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.032</ArticleId><ArticleId IdType="pmc">PMC7332942</ArticleId><ArticleId IdType="pubmed">32629042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q., Zhou J., He Q., Li R.T., Yang G., Zhang Y., Wu S.J., Chen Q., Shi J.H., Zhang R.R., et al. SARS-CoV-2 infection in the mouse olfactory system. Cell Discov. 2021;7:49. doi: 10.1038/s41421-021-00290-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00290-1</ArticleId><ArticleId IdType="pmc">PMC8260584</ArticleId><ArticleId IdType="pubmed">34230457</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Kapur S., Alberts J., Badley A.D., Decker G.A., Rizza S.A., Banerjee R., Banerjee A. Multi-organ impairment in low-risk individuals with long COVID. medRxiv. 2020 doi: 10.1101/2020.10.14.20212555. preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.14.20212555</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med. 2021;27:28&#x2013;33. doi: 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Deleterious outcomes in long-hauler COVID-19: The effects of SARS-CoV-2 on the CNS in chronic COVID syndrome. ACS Chem Neurosci. 2020;11:4017&#x2013;4020. doi: 10.1021/acschemneuro.0c00725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00725</ArticleId><ArticleId IdType="pubmed">33275404</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I., H&#xe4;llqvist J., Gilmour K.C., Grandjean L., Mills K., Heywood W.E. The long tail of Covid-19&#x2019;&#x2014;The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Res. 2020;9:1349. doi: 10.12688/f1000research.27287.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.1</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad U., Pertinez H., Box H., Tatham L., Rajoli R.K.R., Curley P., Neary M., Sharp J., Liptrott N.J., Valentijn A., et al. Prioritization of anti-SARS-Cov-2 drug repurposing opportunities based on plasma and target site concentrations derived from their established human pharmacokinetics. Clin. Pharmacol. Ther. 2021;108:775&#x2013;790. doi: 10.1002/cpt.1909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1909</ArticleId><ArticleId IdType="pmc">PMC7280633</ArticleId><ArticleId IdType="pubmed">32438446</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanafin P.O., Jermain B., Hickey A.J., Kabanov A.V., Kashuba A.D., Sheahan T.P., Rao G.G. A mechanism-based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID-19 treatment in humans. CPT Pharmacomet. Syst. Pharmacol. 2021;10:89&#x2013;99. doi: 10.1002/psp4.12584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/psp4.12584</ArticleId><ArticleId IdType="pmc">PMC7894405</ArticleId><ArticleId IdType="pubmed">33296558</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajoli R.K.R., Pertinez H., Arshad U., Box H., Tatham L., Curley P., Neary M., Sharp J., Liptrott N.J., Valentijn A., et al. Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. Br. J. Clin. Pharmacol. 2021;87:2078&#x2013;2088. doi: 10.1111/bcp.14619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.14619</ArticleId><ArticleId IdType="pmc">PMC8056737</ArticleId><ArticleId IdType="pubmed">33085781</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocan T.M., Basuli F., Stafford R.G., Brown J.L., Zhang X., Duplantier A.J., Swenson R.E. Synthesis of [18F]Favipiravir and biodistribution in C3H/HeN Mice as assessed by positron emission tomography. Sci. Rep. 2019;9:1785. doi: 10.1038/s41598-018-37866-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-37866-z</ArticleId><ArticleId IdType="pmc">PMC6370782</ArticleId><ArticleId IdType="pubmed">30741966</ArticleId></ArticleIdList></Reference><Reference><Citation>Painter G.R., Bowen R.A., Bluemling G.R., DeBergh J., Edpuganti V., Gruddanti P.R., Guthrie D.B., Hager M., Kuiper D.L., Lockwood M.A., et al. The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection. Antivir. Res. 2019;171:104597. doi: 10.1016/j.antiviral.2019.104597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2019.104597</ArticleId><ArticleId IdType="pubmed">31494195</ArticleId></ArticleIdList></Reference><Reference><Citation>EMA (European Medicines Agency)  Remdesivir Gilead&#x2014;Summary on Compassionate use; EMA/178637/2020; 2020.  [(accessed on 8 March 2022)]; Available online:  https://www.ema.europa.eu/en/documents/other/summary-compassionate-use-remdesivir-gilead_en.pdf.</Citation></Reference><Reference><Citation>Jorgensen S.C.J., Kebriaei R., Dresser L.D. Remdesivir: Review of pharmacology, pre-clinical data, and emerging clinical experience for COVID-19. Pharmacotherapy. 2020;40:659&#x2013;671. doi: 10.1002/phar.2429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phar.2429</ArticleId><ArticleId IdType="pmc">PMC7283864</ArticleId><ArticleId IdType="pubmed">32446287</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer O.C., de Lange E.C.M., Breimer D.D., de Boer A.G., Workel J.O., de Kloet E.R. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology. 1998;139:1789&#x2013;1793. doi: 10.1210/endo.139.4.5917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endo.139.4.5917</ArticleId><ArticleId IdType="pubmed">9528963</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>